157 related articles for article (PubMed ID: 26917358)
1. Exfoliative erythroderma after tumor necrosis factor-α inhibitor therapy.
el-Azhary RA; Lehman JS
Int J Dermatol; 2016 Apr; 55(4):e214-5. PubMed ID: 26917358
[No Abstract] [Full Text] [Related]
2. Pigmented lichenoid drug eruption: a new clinical presentation of interface dermatitis induced by anti-TNF alpha drugs.
Darrigade AS; Goussot JF; Milpied B; Taieb A; Seneschal J
Eur J Dermatol; 2016 Dec; 26(6):633-634. PubMed ID: 27634463
[No Abstract] [Full Text] [Related]
3. Solitary facial cutaneous chronic inflammatory lesions induced by anti-tumour necrosis factor-α antagonist.
Haro-Gabaldón V; Ruiz Molina I; Haro-González-Vico V; Solís García E
Clin Exp Dermatol; 2019 Jan; 44(1):80-82. PubMed ID: 30255515
[No Abstract] [Full Text] [Related]
4. Erythroderma following the intradermal injection of the corticosteroid budesonide.
Wilkinson SM; Smith AG; English JS
Contact Dermatitis; 1992 Aug; 27(2):121-2. PubMed ID: 1395620
[No Abstract] [Full Text] [Related]
5. Imiquimod-induced Psoriatic Erythroderma Treated with Infliximab.
Tsutsumi R; Yoshida Y; Yamamoto O
Acta Derm Venereol; 2017 Feb; 97(2):279-280. PubMed ID: 27349505
[No Abstract] [Full Text] [Related]
6. Adalimumab-induced erythrodermic reactions.
Nowsheen S; Kohorst JJ; El-Azhary RA
Int J Dermatol; 2019 Oct; 58(10):e204-e206. PubMed ID: 31135963
[No Abstract] [Full Text] [Related]
7. Infliximab and adalimumab-induced psoriasis in Crohn's disease: a paradoxical side effect.
Iborra M; Beltrán B; Bastida G; Aguas M; Nos P
J Crohns Colitis; 2011 Apr; 5(2):157-61. PubMed ID: 21453886
[TBL] [Abstract][Full Text] [Related]
8. Persistent neutrophilic scarring alopecia triggered by anti-TNF blockade for Crohn's disease.
Amschler K; Mc Broekaert S; Mohr J; Schön MP; Mößner R
Eur J Dermatol; 2018 Jun; 28(3):403-405. PubMed ID: 29976546
[No Abstract] [Full Text] [Related]
9. Histoplasmosis complicating tumor necrosis factor-α blocker therapy: a retrospective analysis of 98 cases.
Vergidis P; Avery RK; Wheat LJ; Dotson JL; Assi MA; Antoun SA; Hamoud KA; Burdette SD; Freifeld AG; McKinsey DS; Money ME; Myint T; Andes DR; Hoey CA; Kaul DA; Dickter JK; Liebers DE; Miller RA; Muth WE; Prakash V; Steiner FT; Walker RC; Hage CA
Clin Infect Dis; 2015 Aug; 61(3):409-17. PubMed ID: 25870331
[TBL] [Abstract][Full Text] [Related]
10. Ketoconazole therapy and exfoliative erythroderma.
Rand R; Sober AJ; Olmstead PM
Arch Dermatol; 1983 Feb; 119(2):97-8. PubMed ID: 6297411
[No Abstract] [Full Text] [Related]
11. Henoch-Schönlein purpura during anti-TNFα therapy: a fortuitous event or an indication to stop therapy?
Pinheiro RR; Lencastre A
Eur J Dermatol; 2017 Jun; 27(3):304-305. PubMed ID: 28468732
[No Abstract] [Full Text] [Related]
12. Infective endocarditis following tumor necrosis factor-α antagonist therapy for management of psoriatic erythroderma: a case report.
Mizuno T; Kiyosawa J; Fukuda A; Watanabe S; Kurose N; Nojima T; Kanda T
J Med Case Rep; 2017 Feb; 11(1):35. PubMed ID: 28179019
[TBL] [Abstract][Full Text] [Related]
13. Paradoxical Autoinflammatory Skin Reaction to Tumor Necrosis Factor Alpha Blockers Manifesting as Amicrobial Pustulosis of the Folds in Patients With Inflammatory Bowel Diseases.
Marzano AV; Tavecchio S; Berti E; Gelmetti C; Cugno M
Medicine (Baltimore); 2015 Nov; 94(45):e1818. PubMed ID: 26559252
[TBL] [Abstract][Full Text] [Related]
14. Psoriasiform exfoliative erythroderma induced by golimumab.
Mateo S; García-Martínez FJ; Sánchez-Aguilar D; Amarelo J; Toribio J
Clin Exp Dermatol; 2014 Oct; 39(7):813-5. PubMed ID: 25156341
[TBL] [Abstract][Full Text] [Related]
15. Follicular eruption with folliculotropic lymphocytic infiltrates associated with anti-tumor necrosis factor alpha therapy: Report and study of 3 cases.
Avitan-Hersh E; Dias-Polak D; Ramon M; Zaaroura H; Sahar D; Bergman R
J Cutan Pathol; 2020 Feb; 47(2):113-120. PubMed ID: 31595531
[TBL] [Abstract][Full Text] [Related]
16. TNF-α inhibitor (adalimumab) induced psoriasis: a case report.
Al-Mutairi A; Elkashlan M; Al-Fayed HM; Swayed M
Australas J Dermatol; 2012 May; 53(2):157. PubMed ID: 22571571
[No Abstract] [Full Text] [Related]
17. Photoallergic erythroderma due to doxycycline therapy of erythema chronicum migrans.
Kuznetsov AV; Weisenseel P; Flaig MJ; Ruzicka T; Prinz JC
Acta Derm Venereol; 2011 Oct; 91(6):734-6. PubMed ID: 21681354
[No Abstract] [Full Text] [Related]
18. Warfarin-induced erythroderma.
Rowe CJ; Robertson I; James D; McMeniman E
Australas J Dermatol; 2015 Feb; 56(1):e15-7. PubMed ID: 24592901
[TBL] [Abstract][Full Text] [Related]
19. Severe exfoliative dermatitis caused by esomeprazole.
Mumoli N; Luschi R; Camaiti A; Cei M; Bagnoni G; Biondi A
J Am Geriatr Soc; 2011 Dec; 59(12):2377-8. PubMed ID: 22188084
[No Abstract] [Full Text] [Related]
20. Autoimmune hepatitis and anti-tumor necrosis factor alpha therapy: A single center report of 8 cases.
Rodrigues S; Lopes S; Magro F; Cardoso H; Horta e Vale AM; Marques M; Mariz E; Bernardes M; Lopes J; Carneiro F; Macedo G
World J Gastroenterol; 2015 Jun; 21(24):7584-8. PubMed ID: 26140007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
